<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-CT4MUIJD</identifier><date>2014</date><creator>Jezeršek Novaković, Barbara</creator><relation>documents/doc/C/URN_NBN_SI_doc-CT4MUIJD_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CT4MUIJD_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 88-95</format><identifier identifier_type="COBISSID_HOST">1896827</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CT4MUIJD</identifier><language>slv</language><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Malignomi krvotvornega in limfatičnega tkiva</source><rights>InC</rights><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="slv">maligni limfomi</subject><subject language_type_id="slv">monoklonska protitelesa</subject><subject language_type_id="slv">sistemsko zdravljenje</subject><title>Zreli limfomi celic B, T in NK</title></Record>